0001396677-15-000024.txt : 20150428 0001396677-15-000024.hdr.sgml : 20150428 20150428151830 ACCESSION NUMBER: 0001396677-15-000024 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20150424 FILED AS OF DATE: 20150428 DATE AS OF CHANGE: 20150428 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: NUTRACEUTICAL INTERNATIONAL CORP CENTRAL INDEX KEY: 0001050007 STANDARD INDUSTRIAL CLASSIFICATION: MEDICINAL CHEMICALS & BOTANICAL PRODUCTS [2833] IRS NUMBER: 870515089 STATE OF INCORPORATION: DE FISCAL YEAR END: 0930 BUSINESS ADDRESS: STREET 1: 1400 KEARNS BOULEVARD STREET 2: 2ND FLOOR CITY: PARK CITY STATE: UT ZIP: 84060 BUSINESS PHONE: 4356556000 MAIL ADDRESS: STREET 1: 1400 KEARNS BOULEVARD STREET 2: 2ND FLOOR CITY: PARK CITY STATE: UT ZIP: 84060 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: SOPER STANLEY E CENTRAL INDEX KEY: 0001265855 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 000-23731 FILM NUMBER: 15798277 MAIL ADDRESS: STREET 1: C/O NUTRACEUTICAL INTERNATIONAL CORP STREET 2: 1400 KEARNS BLVD 2ND FL. CITY: PARK CITY STATE: UT ZIP: 84060 4 1 primary_doc.xml PRIMARY DOCUMENT X0306 4 2015-04-24 0 0001050007 NUTRACEUTICAL INTERNATIONAL CORP NUTR 0001265855 SOPER STANLEY E C/O NUTRACEUTICAL INTERNATIONAL CORP 1400 KEARNS BLVD 2ND FL. PARK CITY UT 84060 0 1 0 0 VP, Legal Affairs Common Stock 2015-04-24 4 M 0 100 14.22 A 100 D Common Stock 2015-04-24 4 S 0 100 20 D 0 D Common Stock 2015-04-27 4 M 0 3243 14.22 A 3243 D Common Stock 2015-04-27 4 S 0 3243 20.0038 D 0 D Employee Stock Option (right to buy) 14.22 2015-04-24 4 M 0 100 0 D 2005-09-30 2015-09-30 Common Stock 100 20546 D Employee Stock Option (right to buy) 14.22 2015-04-27 4 M 0 3243 0 D 2005-09-30 2015-09-30 Common Stock 3243 17312 D Exercise of options expiring on September 30, 2015. The sale reported in this Form 4 effected pursuant to a Rule 10b5-1 plan adopted by the reporting person on February 9, 2015. The price shown in Column 4 is a weighted average sale price. The price range for the sales is $20.00 to $20.03. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer or a security holder of the Issuer, full information regarding the number of shares sold at each separate price. The option immediately vested at the time of grant. /s/ Alison Pitt, attorney in fact 2015-04-28